Aims/hypothesis. L-type calcium current (I Ca,L ) is a major determinant of mammalian cardiac contraction, and data from studies performed at room temperature suggest that this current is stimulated by insulin. This investigation aimed to determine whether or not insulin stimulates cardiac I Ca,L at 37°C. Methods. Isolated guinea pig ventricular myocytes were studied at room temperature and at 37°C. Myocytes were either field stimulated or whole-cell voltage clamped, and cell shortening was measured using video edge detection. Results. Insulin stimulated I Ca,L at ambient temperature. However, at 37°C the effect of insulin was to decrease rather than to increase I Ca,L . This action was concentration dependent and was not associated with voltage shifts in steady-state activation or inactivation properties of I Ca,L . At 37°C, insulin increased the extent of myocyte contraction despite producing a significant decrease in I Ca,L amplitude. Conclusions/interpretation. The findings of this study indicate that temperature is a key experimental variable in the study of the physiological actions of insulin. Furthermore, the increase in cardiac cell contraction by insulin at physiological temperature is not due to an increase in I Ca,L , but is probably due to stimulation of excitation-contraction coupling downstream of I Ca,L .
Introduction
An increased risk of heart diseases, such as cardiomyopathy and heart failure, is a recognised complication of diabetes. Moreover, insulin exerts a positive inotropic effect (an increase in the strength of muscular con-
Results and discussion
Figures 1a and b show representative I Ca,L records and mean data in the absence and presence of 1 µmol/l insulin at room temperature (18-21°C). These data confirm previous reports [4, 5] , showing an increase in I Ca,L magnitude with insulin (t test; p<0.05). Figures  1c and d show corresponding data at 37°C. Surprisingly, and in marked contrast with the room temperature data, at 37°C insulin decreased the magnitude of I Ca,L (p<0.05). This difference in insulin action between room temperature and 37°C was also observed when I Ca,L was normalised to cell size (membrane capacitance). The inhibitory effect of insulin at 37°C was concentration dependent (Fig. 1e) . The significant inhibitory effect (p<0.05) at a relatively low insulin concentration (100 nmol/l) suggests that this finding has physiological and pathological relevance. Halfmaximal activation voltage and slope factor parameters derived from Boltzmann fits to current-voltage plots [7] were −11.25±2.29 mV and 7.55±1.01 mV respectively in controls (n=5), and −11.10±1.36 mV (p>0.1 vs control) and 4.56±0.32 mV (p<0.05 vs control) respectively in 1 µmol/l insulin (n=5). For voltage-dependent inactivation, half-maximal inactivation voltage and slope factor values were −30.60±1.58 mV and 7.10±1.13 mV respectively in controls (n=5), and −27.53±2.27 mV and 9.03±1.05 mV (both p>0.05 vs control) respectively in 1 µmol/l insulin (n=6). These mean values were used to produce the activation and inactivation plots in Fig. 1f [7] , where the relations for control and insulin tests are closely overlaid. Thus, in contrast to previous data from vascular smooth muscle cells [8] , the decrease in cardiac I Ca,L with insulin did not correlate with shifts in voltage-dependent I Ca,L kinetics.
It is well known that I Ca,L provides the main source of sarcolemmal Ca 2+ entry for the process of calciuminduced calcium release during cardiac excitation-contraction coupling [9] . Intriguingly, a previous study has shown no positive inotropic effect of insulin on cultured normal ventricular myocytes at 30°C [10] . Figure 2a shows that cell shortening of field-stimulated, undialysed myocytes at 37°C was greater in the presence of insulin (1 µmol/l). Mean control shortening was 19.14±1.55% resting cell length (n=8); shortening with insulin was 27.47±0.97% resting cell length (n=8). The positive inotropic effect observed under these conditions clearly indicates a direct inotropic effect of insulin on cardiac myocytes, independent of any effects of insulin on other cardiovascular tissues (e.g. the microvasculature). Further experiments were performed on patch-clamped cells to enable joint measurement of cell shortening and I Ca,L . Figure 2b shows representative recordings under control and insulin conditions, whilst Figs. 2c and d show mean data for cell shortening and I Ca,L amplitude respectively. In absolute terms, cell shortening from
Materials and methods
Myocyte isolation and application of insulin. Male guinea pigs (400-600 g) were humanely killed using a UK Home Officeapproved 'Schedule 1' procedure. Ventricular myocytes were isolated using an enzymatic dispersal method as previously described [6] , then placed in a recording chamber and superfused with Tyrode's solution containing 140 mmol/l NaCl, 5 mmol/l HEPES, 10 mmol/l glucose, 4 mmol/l KCl, 2.5 mmol/l CaCl 2 and 1 mmol/l MgCl 2 (pH adjusted to 7.45 using NaOH). Aristar grade chemicals were used (BDH, Poole, Dorset, UK). Insulin (bovine pancreas; Sigma-Aldrich, Gillingham, Dorset, UK) was added to this solution from a 35-mmol/l stock solution made up in water, adjusted to pH 2 with HCl. Prior to recording, cells were pre-incubated for 10 min in normal Tyrode's solution alone (Control), or in insulin-containing Tyrode's solution ([Insulin], with insulin also present throughout recording). An insulin concentration of 1 µmol/l was used in all experiments presented in the 'Results and discussion', except when concentration-dependent modulation of I Ca,L was studied (Fig. 1e) , for which a range of concentrations between 100 nmol/l and 1 µmol/l were tested.
Voltage clamp technique. Whole-cell patch clamp experiments were performed using an Axopatch 200A amplifier (Axon Instruments, Union City, Calif., USA). The methods for preparing patch pipettes and for acquiring and processing data have already been described [7] .
L-type Ca2+ current (ICa,L) measurement.
A Cs + -based internal dialysis solution was used for selective I Ca,L recording. Its composition was as follows: 113 mmol/l CsCl (to block outward K + currents); 5 mmol/l K 2 ATP; 0.4 mmol/l MgCl 2 ; 2 mmol/l K 2 EGTA (to block Ca 2+ -activated currents); 5 mmol/l glucose; 10 mmol/l HEPES. The solution was titrated to pH 7.2 using CsOH. After the whole-cell configuration had been attained, K + -free Tyrode's solution was applied to inhibit inwardly rectifying K + current. As described previously, I Ca,L was elicited by a two-step voltage protocol [7] . A prepulse from −80 mV to −40 mV, to activate and then inactivate the fast Na + current, was followed by a test pulse to +10 mV to elicit I Ca,L (records in Fig. 1 show only the current during the +10 mV test pulse). Voltage-dependent activation and inactivation plots for I Ca,L were obtained using the protocols shown schematically in Fig. 1g , reconstructing mean activation and inactivation relations as described previously [8] .
Measuring unloaded cell shortening of isolated ventricular myocytes at 37°C. For this part of the study we used a videobased edge detection system (Crescent Electronics, Sandy, Utah, USA). For experiments on undialysed cells, myocytes were field stimulated at 0.2 Hz. Where cell shortening and ionic currents were measured concurrently, patch pipettes were filled with a 'physiological' K + -based pipette solution of 113 mmol/l KCl, 10 mmol/l NaCl, 5 mmol/l K 2 ATP, 0.4 mmol/l MgCl 2 , 5 mmol/l glucose and 10 mmol/l HEPES. The solution was titrated to pH 7.2 with KOH. Lidocaine (200 µmol/l) was present in the external solution to block any residual Na + current.
Data analysis. Data are expressed as means ± SEM. Numbers of cells from which particular observations were obtained are given in parentheses in the 'Results and discussion' or in the figure legends. Statistical comparisons were made using the Student's t test or analysis of variance where appropriate. Statistical significance was accepted as p being less than 0.05. patch-clamped cells was less than that observed from field-stimulated cells, possibly as a result of equilibration of intracellular contents with the pipette dialysate in these experiments. Nevertheless, cell shortening in dialysed cells was increased by insulin, whilst I Ca,L amplitude was decreased (Fig. 2d) .
Three main conclusions can be drawn from this study. Firstly, cardiac effects of insulin observed at ambient temperature cannot be extrapolated to the physiological situation at 37°C. This conclusion may also be relevant to the interpretation and design of studies of insulin action on other tissues and organs. Secondly, the signalling pathways downstream of the insulin receptor and/or the interaction between insulin and its receptor in cardiac myocytes are sufficiently temperature sensitive for the net effects of insulin receptor activation on whole-cell I Ca,L to be opposite at room temperature from those at 37°C. The stimulatory effect of insulin on I Ca,L at room temperature reported , n=22; insulin, n=10) . (e) Concentration dependence of insulin effect on I Ca,L at 37°C (control, n=22; 100 nmol/l insulin, n=5; 500 nmol/l insulin, n=7; 1000 nmol/l insulin, n=10). (f) Steady-state voltage-dependent activation (left) and inactivation (right) curves without (■) or with (■ ■) insulin. Halfmaximal voltage and slope factor values for activation and for inactivation were derived from experiments with protocols shown in insets and were then used to simulate activation and inactivation variables at 2 mV intervals previously [4, 5] was attributed to a stimulation of cyclic adenosine monophosphate-dependent protein kinase. Clearly, the pathways responsible for the inhibitory effect of insulin on I Ca,L at 37°C must now be elucidated. Thirdly, the positive inotropic action of insulin, reported in the intact normal heart, is the result of direct action of insulin on myocytes, which cannot be explained by a stimulation of Ca 2+ entry via I Ca,L .
Rather, the overall 'gain' of the excitation-contraction coupling process was increased. Further investigations are warranted in order to determine which steps of the process are modulated by insulin to account for the observed inotropic effect at physiological temperature. These will probably need to combine the techniques used in the present study with measurements of intracellular Ca 2+ to determine: (i) the effects of insulin on intracellular Ca 2+ handling (particularly by the intracellular stores in the sarcoplasmic reticulum) and on myofilament Ca 2+ sensitivity; and (ii) whether and how the I Ca,L and contraction of diabetic and normal hearts differ in their response to insulin. Collectively, the present data and the proposed future work will provide information valuable to the rational development of strategies to protect and treat the myocardium in diabetic and non-diabetic patients.
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